Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONGeneric

SEFFIN

CEPHALOTHIN SODIUM

Standard Dose
EQ 10GM BASE/VIAL
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview SEFFIN is listed in Drugs@FDA under application 062435 (ANDA).

Marketing status: Discontinued Active ingredient CEPHALOTHIN SODIUM Form and strength INJECTABLE;INJECTION - EQ 10GM BASE/VIAL Sponsor GLAXOSMITHKLINE Submission history See approval history documents.

Structured Monograph

Clinical summary

Approval overview SEFFIN is listed in Drugs@FDA under application 062435 (ANDA). Marketing status: Discontinued Active ingredient CEPHALOTHIN SODIUM Form and strength INJECTABLE;INJECTION - EQ 10GM BASE/VIAL Sponsor GLAXOSMITHKLINE Submission history See approval history documents.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.